In this Issue:
Apremilast effective in Behçet’s syndrome
Considering bDMARDs after anti-TNF failure
Methotrexate auto-injector well tolerated
Assessing methotrexate exposure
Effects of increasing methotrexate dose + adalimumab
SC vs IV tocilizumab: comparable efficacy
Don’t stop tocilizumab after sustained clinical remission
Tocilizumab dose reduction feasible
Stopping bDMARDs prior to surgery and infection risks
TNFi may reduce diabetes risk in RA
Exercise benefits ankylosing spondylitis
Silent strokes are prevalent in SLE
Colchicine protects against MI in gout?
Denosumab: preferred option in high-risk fracture?
Please login below to download this issue (PDF)